U.S. flag An official website of the United States government
  1. Home
  2. For Health Professionals
  3. Learning Activities
  1. For Health Professionals

CDERLearn in the Center for Drug Evaluation and Research (CDER) offers a variety of learning opportunities for healthcare professionals, industry, consumers, and academia. The goal is to create a body of educational and information modules about human drug regulation and activities. CDERLearn is a way to share FDA expertise in specific subject areas to further instruct the public about the many ways CDER protects and promotes public health. CDERLearn


Sub-Topic Paragraphs

Latest From the Commissioner

Examining Medical Product Development in the Wake of the Ebola Epidemic -

Mar 29

Examining Ways to Combat Antibiotic Resistance and Foster New Drug Development - 06/14/2017

Feb 16

Researching the Potential Medical Benefits and Risks of Marijuana - 07/12/2016

Feb 20

Reviewing the Rising Price of EpiPens - 09/21/2016

Feb 16

Exploring a Right to Try for Terminally Ill Patients - 09/22/2016

Sep 22

Prioritizing Public Health: The FDA’s Role in the Generic Drug Marketplace - 09/26/2016

Feb 16

Waste and Duplication in the USDA Catfish Inspection Program - 12/07/2016

Feb 20

Prescription Drug User Fee Act Reauthorization (PDUFA VI), Medical Device User Fee Act Reauthorization (MDUFA IV), Generic Drug User Fee Act Reauthorization (GDUFA II), and Biosimilar User Fee Act Reauthorization (BsUFA II) - 03/21/2017

Feb 20


Stakeholder Update

FDA's Stakeholder Engagement Staff works to provide you with up-to-date information that helps to further our commitment in advancing public health and well-being.

Back to Top